Compare NC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NC | CYRX |
|---|---|---|
| Founded | 1913 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.3M | 421.6M |
| IPO Year | 2006 | 2008 |
| Metric | NC | CYRX |
|---|---|---|
| Price | $49.13 | $8.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | 9.7K | ★ 358.4K |
| Earning Date | 06-15-2026 | 06-04-2026 |
| Dividend Yield | ★ 2.06% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ 2.35 | 1.40 |
| Revenue | $104,778,000.00 | ★ $176,177,000.00 |
| Revenue This Year | N/A | $9.71 |
| Revenue Next Year | N/A | $9.56 |
| P/E Ratio | $20.84 | ★ $5.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $30.00 | $4.63 |
| 52 Week High | $59.42 | $11.45 |
| Indicator | NC | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.43 | 37.93 |
| Support Level | $45.03 | $6.57 |
| Resistance Level | $55.09 | $8.45 |
| Average True Range (ATR) | 2.41 | 0.50 |
| MACD | -1.04 | 0.03 |
| Stochastic Oscillator | 30.99 | 27.14 |
NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.